Gsk Operating Expenses Growth & History (GSK)

Gsk's operating expenses was £15.72B for fiscal 2025.

View full Gsk company overview

Gsk annual operating expenses history

Gsk annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31£15.72B−£2.59B−14.14%
20242024-12-31£18.31B£3.29B+21.90%
20232023-12-31£15.02B£1.68B+12.60%
20222022-12-31£13.34B£1.16B+9.54%
20212021-12-31£12.18B£1.73B+16.56%
20202020-12-31£10.45B−£4.48B−30.03%
20192019-12-31£14.93B−£167.0M−1.11%
20182018-12-31£15.10B−£660.0M−4.19%
20172017-12-31£15.76B−£244.0M−1.52%
20162016-12-31£16.00B£11.25B+237.01%
20152015-12-31£4.75B

Gsk operating expenses trends

Over the last five fiscal years, Gsk's operating expenses increased from £10.45B to £15.72B, a change of £5.27B. The latest reported quarter, Q2 2026, shows £5.66B.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Gsk source filings ↗

Community posts

It’s quiet here.

No posts about GSK yet. Start the conversation.

Write the first post